Xencor (XNCR) Appoints Bart Cornelissen as Chief Financial Officer
Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious diseases, today announced the appointment of Bart Cornelissen [alumnus RSM…
Outlet:
StreetInsider.com
Media Type:
Online
Tuesday, 9 April 2024